Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.
Identifieur interne : 000453 ( PubMed/Corpus ); précédent : 000452; suivant : 000454Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.
Auteurs : Ruth Harvey ; Giada Mattiuzzo ; Mark Hassall ; Andrea Sieberg ; Marcel A. Müller ; Christian Drosten ; Peter Rigsby ; Christopher J. OxenfordSource :
- Emerging infectious diseases [ 1080-6059 ] ; 2019.
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) was detected in humans in 2012. Since then, sporadic outbreaks with primary transmission through dromedary camels to humans and outbreaks in healthcare settings have shown that MERS-CoV continues to pose a threat to human health. Several serologic assays for MERS-CoV have been developed globally. We describe a collaborative study to investigate the comparability of serologic assays for MERS-CoV and assess any benefit associated with the introduction of a standard reference reagent for MERS-CoV serology. Our study findings indicate that, when possible, laboratories should use a testing algorithm including >2 tests to ensure correct diagnosis of MERS-CoV. We also demonstrate that the use of a reference reagent greatly improves the agreement between assays, enabling more consistent and therefore more meaningful comparisons between results.
DOI: 10.3201/eid2510.190497
PubMed: 31423969
Links to Exploration step
pubmed:31423969Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.</title>
<author><name sortKey="Harvey, Ruth" sort="Harvey, Ruth" uniqKey="Harvey R" first="Ruth" last="Harvey">Ruth Harvey</name>
</author>
<author><name sortKey="Mattiuzzo, Giada" sort="Mattiuzzo, Giada" uniqKey="Mattiuzzo G" first="Giada" last="Mattiuzzo">Giada Mattiuzzo</name>
</author>
<author><name sortKey="Hassall, Mark" sort="Hassall, Mark" uniqKey="Hassall M" first="Mark" last="Hassall">Mark Hassall</name>
</author>
<author><name sortKey="Sieberg, Andrea" sort="Sieberg, Andrea" uniqKey="Sieberg A" first="Andrea" last="Sieberg">Andrea Sieberg</name>
</author>
<author><name sortKey="Muller, Marcel A" sort="Muller, Marcel A" uniqKey="Muller M" first="Marcel A" last="Müller">Marcel A. Müller</name>
</author>
<author><name sortKey="Drosten, Christian" sort="Drosten, Christian" uniqKey="Drosten C" first="Christian" last="Drosten">Christian Drosten</name>
</author>
<author><name sortKey="Rigsby, Peter" sort="Rigsby, Peter" uniqKey="Rigsby P" first="Peter" last="Rigsby">Peter Rigsby</name>
</author>
<author><name sortKey="Oxenford, Christopher J" sort="Oxenford, Christopher J" uniqKey="Oxenford C" first="Christopher J" last="Oxenford">Christopher J. Oxenford</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31423969</idno>
<idno type="pmid">31423969</idno>
<idno type="doi">10.3201/eid2510.190497</idno>
<idno type="wicri:Area/PubMed/Corpus">000453</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000453</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.</title>
<author><name sortKey="Harvey, Ruth" sort="Harvey, Ruth" uniqKey="Harvey R" first="Ruth" last="Harvey">Ruth Harvey</name>
</author>
<author><name sortKey="Mattiuzzo, Giada" sort="Mattiuzzo, Giada" uniqKey="Mattiuzzo G" first="Giada" last="Mattiuzzo">Giada Mattiuzzo</name>
</author>
<author><name sortKey="Hassall, Mark" sort="Hassall, Mark" uniqKey="Hassall M" first="Mark" last="Hassall">Mark Hassall</name>
</author>
<author><name sortKey="Sieberg, Andrea" sort="Sieberg, Andrea" uniqKey="Sieberg A" first="Andrea" last="Sieberg">Andrea Sieberg</name>
</author>
<author><name sortKey="Muller, Marcel A" sort="Muller, Marcel A" uniqKey="Muller M" first="Marcel A" last="Müller">Marcel A. Müller</name>
</author>
<author><name sortKey="Drosten, Christian" sort="Drosten, Christian" uniqKey="Drosten C" first="Christian" last="Drosten">Christian Drosten</name>
</author>
<author><name sortKey="Rigsby, Peter" sort="Rigsby, Peter" uniqKey="Rigsby P" first="Peter" last="Rigsby">Peter Rigsby</name>
</author>
<author><name sortKey="Oxenford, Christopher J" sort="Oxenford, Christopher J" uniqKey="Oxenford C" first="Christopher J" last="Oxenford">Christopher J. Oxenford</name>
</author>
</analytic>
<series><title level="j">Emerging infectious diseases</title>
<idno type="eISSN">1080-6059</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Middle East respiratory syndrome coronavirus (MERS-CoV) was detected in humans in 2012. Since then, sporadic outbreaks with primary transmission through dromedary camels to humans and outbreaks in healthcare settings have shown that MERS-CoV continues to pose a threat to human health. Several serologic assays for MERS-CoV have been developed globally. We describe a collaborative study to investigate the comparability of serologic assays for MERS-CoV and assess any benefit associated with the introduction of a standard reference reagent for MERS-CoV serology. Our study findings indicate that, when possible, laboratories should use a testing algorithm including >2 tests to ensure correct diagnosis of MERS-CoV. We also demonstrate that the use of a reference reagent greatly improves the agreement between assays, enabling more consistent and therefore more meaningful comparisons between results.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">31423969</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>10</Issue>
<PubDate><Year>2019</Year>
<Month>10</Month>
</PubDate>
</JournalIssue>
<Title>Emerging infectious diseases</Title>
<ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.</ArticleTitle>
<Pagination><MedlinePgn>1878-1883</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2510.190497</ELocationID>
<Abstract><AbstractText>Middle East respiratory syndrome coronavirus (MERS-CoV) was detected in humans in 2012. Since then, sporadic outbreaks with primary transmission through dromedary camels to humans and outbreaks in healthcare settings have shown that MERS-CoV continues to pose a threat to human health. Several serologic assays for MERS-CoV have been developed globally. We describe a collaborative study to investigate the comparability of serologic assays for MERS-CoV and assess any benefit associated with the introduction of a standard reference reagent for MERS-CoV serology. Our study findings indicate that, when possible, laboratories should use a testing algorithm including >2 tests to ensure correct diagnosis of MERS-CoV. We also demonstrate that the use of a reference reagent greatly improves the agreement between assays, enabling more consistent and therefore more meaningful comparisons between results.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harvey</LastName>
<ForeName>Ruth</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mattiuzzo</LastName>
<ForeName>Giada</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hassall</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sieberg</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Müller</LastName>
<ForeName>Marcel A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Drosten</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rigsby</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Oxenford</LastName>
<ForeName>Christopher J</ForeName>
<Initials>CJ</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>study participants</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2019</Year>
<Month>10</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Emerg Infect Dis</MedlineTA>
<NlmUniqueID>9508155</NlmUniqueID>
<ISSNLinking>1080-6040</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">MERS-CoV</Keyword>
<Keyword MajorTopicYN="Y">Middle East respiratory syndrome coronavirus</Keyword>
<Keyword MajorTopicYN="Y">Oman</Keyword>
<Keyword MajorTopicYN="Y">Saudi Arabia</Keyword>
<Keyword MajorTopicYN="Y">South Korea</Keyword>
<Keyword MajorTopicYN="Y">antibodies</Keyword>
<Keyword MajorTopicYN="Y">diagnostics</Keyword>
<Keyword MajorTopicYN="Y">serology</Keyword>
<Keyword MajorTopicYN="Y">standard</Keyword>
<Keyword MajorTopicYN="Y">viruses</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2019</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">31423969</ArticleId>
<ArticleId IdType="doi">10.3201/eid2510.190497</ArticleId>
<ArticleId IdType="pmc">PMC6759245</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>PLoS One. 2014 Mar 06;9(3):e90383</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24603704</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2015 Jul;21(7):1153-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26079346</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2016 Jul 7;22(7):701-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27387881</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Transfusion. 2009 Sep;49(9):1931-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19497061</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Viruses. 2018 Aug 13;10(8):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30104551</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Infect Control Hosp Epidemiol. 2019 Jan;40(1):79-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30595141</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Virol. 2015 Aug;69:81-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26209385</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2018 Nov;159:35-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30236531</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000453 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000453 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:31423969 |texte= Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:31423969" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |